BORTEZOMIB IS ABLE TO INACTIVATE NF-KB AND DOWN-REGULATE WT1 GENE IN P39 CELL LINE: A POSSIBLE USE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES?
Autor: | Galimberti, S., Canestraro, M. C. H. D., MD SAVLI, H., G. A., Md, Phd, Palumbo, PHD NAGY, B., DI RAIMONDO, Francesco, MD PETRINI, M. |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2008 |
Databáze: | OpenAIRE |
Externí odkaz: |